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The impact of self-perceived 
limitations, stigma and sense of 
coherence on quality of life in 
multiple sclerosis patients: results  
of a cross-sectional study
Feddrik Broersma1, Barth Oeseburg2, Jacob Dijkstra3 
and Klaske Wynia1,4
Abstract
Objective: To examine the impact of perceived limitations, stigma and sense of coherence on quality of 
life in multiple sclerosis patients.
Design: Cross-sectional survey.
Setting: Department of Neurology, University Medical Center Groningen, the Netherlands.
Subjects: Multiple sclerosis patients.
Main measures: World Health Organization Quality of Life – abbreviated version, Stigma Scale for 
Chronic Illness, Sense of Coherence Scale, background and disease-related questions.
Results: In total, 185 patients (61% response rate) participated in the study with moderate to severe 
limitations. Stigma was highly prevalent but low in severity. Patients with a higher sense of coherence 
experienced a lower level of limitations (B = −0.063, P < 0.01) and less stigma (enacted stigma B = −0.030, 
P < 0.01; self-stigma B = −0.037, P < 0.01). Patients with a higher level of limitations experienced more 
stigma (enacted stigma B = 0.044, P < 0.05; self-stigma B = 0.063, P < 0.01). Patients with a higher sense 
of coherence experienced better quality of life (physical health B = 0.059, P < 0.01; psychological health 
B = 0.062, P < 0.01; social relationships B = 0.052, P < 0.01; environmental aspects B = 0.030, P < 0.01). 
Patients with a higher level of limitations experienced poorer quality of life (physical health B = −0.364, P 
< 0.01; psychological health B = −0.089, P < 0.05) and patients with more stigma also experienced poorer 
quality of life (self-stigma: physical health B = −0.073, P < 0.01; psychological health B = −0.089, P < 0.01; 
social relationships B = −0.124, P < 0.01; environmental aspects B = −0.052, P < 0.01, and enacted stigma: 
physical health B = −0.085, P < 0.10).
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Conclusion: Patients with less perceived limitations and stigma and a higher level of sense of coherence 
experienced better quality of life. Patients with a higher sense of coherence experienced a lower level of 
limitations and less stigma.
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Introduction
The relationship between perceived limitations, a 
feeling of stigmatization and sense of coherence on 
one hand and quality of life on the other hand is 
generally unknown, specifically in patients with 
multiple sclerosis. Multiple sclerosis is a chronic 
disease with an unpredictable course.1 Patients 
may suffer from physical limitations and psycho-
social challenges impacting quality of life. Stigma 
is a psychosocial challenge arising when individu-
als or groups exhibit characteristics which render 
them inferior in the eyes of others, resulting in 
devaluation, rejection or exclusion.2 A distinction 
can be made between actual stigmatization, 
referred to as enacted stigma, and the anticipation, 
fear or internalization of actual stigma, referred to 
as felt or self-stigma. Once self-stigma affects a 
person’s identity, it can cause, for example, low 
self-esteem and depression.3,4 It is known that 
stigma impacts quality of life negatively in chronic 
diseases such as mental illnesses, irritable bowel 
syndrome and neuromuscular diseases.5–7
An important factor regarding the extent to which 
limitations due to multiple sclerosis and stigma affect 
quality of life might be a patients’ sense of coher-
ence, which according to Antonovsky is a way of 
perceiving the world that enables patients to cope 
with encountered stressors.8 Sense of coherence has 
been associated positively with quality of life in sev-
eral chronic diseases, such as inflammatory bowel 
disease9 and Parkinson’s disease,10 and has been 
shown to have mediating and moderating effects on 
the impact of stressors on health.11–14 However, 
knowledge about the combined impact of limita-
tions, stigma and sense of coherence on quality of 
life in multiple sclerosis patients is lacking.
Therefore, the objective of this study is to exam-
ine the impact of perceived limitations, stigma and 
sense of coherence on quality of life in multiple 
sclerosis patients. We expect that (a) limitations 
have a negative impact on stigma, (b) limitations 
and stigma have a negative impact on quality of 
life and (c) sense of coherence has a positive impact 
on limitations, stigma and quality of life.
Methods
We conducted a cross-sectional survey as a part of 
a cohort study which began in 2004.15,16 The 2004 
cohort initially consisted of 378 multiple sclerosis 
patients attending the Groningen Multiple 
Sclerosis Center of the Department of Neurology 
at the University Medical Center Groningen, the 
Netherlands. For this study, we checked the vital 
status of the cohort in the national population reg-
ister. This yielded 76 deaths in a 10-year period 
(20%). The remaining patients (n = 302) were eli-
gible for assessment in 2014 and received an invi-
tation letter with a request to participate in the 
study by completing a survey online.
The survey included demographic and disease-
related questions and questionnaires for disease 
severity, stigma, sense of coherence and quality of 
life. Patients were invited to answer questions 
online, on a website which was specifically 
designed for this study. The invitation letter also 
offered patients the option to request a hardcopy 
version of the questionnaires, which was then sent 
by post. After two weeks, non-responders were 
sent a reminder, which included a hardcopy version 
of the questionnaires. To reduce item non-response, 
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patients returning incomplete questionnaires were 
interviewed by phone. A group of 185 patients 
agreed to participate in the study (61% response 
rate). In total, 55 (30%) of these patients completed 
the survey online. The study was presented to the 
ethical review board of the University Medical 
Center Groningen, which deemed further ethical 
scrutiny unnecessary.
Measurement instruments
All data used in this study were retrieved from the 
patients’ questionnaires. Included background var-
iables were gender, age, marital status, educational 
level and employment status. Disease-related vari-
ables were disease progression, years since diagno-
sis and level of disability.
To evaluate disease progression, we used a sin-
gle question asking how the disease had developed 
during the past six months. Responses can be cat-
egorized into three types of progression: relapsing 
remitting, secondary progressive and primary pro-
gressive multiple sclerosis.17 Since these types are 
based on self-reports, they are similar but not 
equivalent to distinctions in disease progression 
made by a neurologist.
To evaluate the level of disability, we used the 
valid and reliable ambulation question from the 
self-report version of the Expanded Disability 
Status Scale.18 The score can range from 0 (no 
disability) and can increase with half point incre-
ments to a score of 10 (death due to multiple scle-
rosis). Scores can be categorized into three 
groups: ‘walking without assistance’ with a walk-
ability of more than 500 m without assistance 
(Expanded Disability Status Scale 4 or less); 
‘walking with assistance’ comprising a walkabil-
ity of 300 m or less without help or with canes 
(Expanded Disability Status Scale 4.5–7) and 
‘wheelchair or bed’ comprising a complete or par-
tial restriction to a wheelchair or bed (Expanded 
Disability Status Scale 7 or more). These group-
ings reflect clinical judgement by coinvestigators 
with expertise in multiple sclerosis care.18,19
To assess the extent of their limitations, patients 
were asked to give an overall rating of the extent 
of limitations they experience by answering the 
question ‘To what extent are you limited due to mul-
tiple sclerosis?’ on a visual analogue scale, ranging 
from 0 (not limited) to 10 (severely limited).20 
Quality of life was assessed using the Dutch 
World Health Organization Quality of Life meas-
urement instrument – abbreviation version.21 This 
measurement instrument consists of 24 items 
distributed across four subscales. The subscales 
assess four quality-of-life domains: physical 
health, psychological health, social relations 
and environmental aspects. Each scale item was 
summed and transformed to a scale ranging from 
0 (worst health) to 20 (best health). The Dutch 
version showed good reliability.16 
To assess stigma, we used the Dutch version of 
the Stigma Scale for Chronic Illness.22 The Stigma 
Scale for Chronic Illness consists of 24 items, distrib-
uted across two subscales: enacted stigma (11 items) 
and self-stigma (13 items). The enacted stigma scale 
measures experienced discrimination and exclusion. 
The self-stigma scale measures shame and fear of 
discrimination and exclusion. Response options 
range between 0 (never) and 4 (always). Items for 
each scale were summed to a total score (0–44 
enacted stigma and 0–52 self-stigma). Higher scores 
indicate more stigma. The Dutch version showed 
good internal consistency among patients.7
Sense of coherence was assessed using the 
Dutch version of Antonovsky’s Sense of Coherence 
Scale.23,24 The Sense of Coherence Scale consists 
of 13 items and assesses three theoretical compo-
nents: comprehensibility, manageability and mean-
ingfulness. Scores range from 1 (very seldom or 
never) to 7 (very often) and were summed to a total 
score (ranging from 13 to 91). The Sense of 
Coherence scale showed satisfactory levels of 
internal consistency.25
Analysis
We first used descriptive statistics to examine patient 
characteristics, the extent of limitations, stigma, sense 
of coherence and quality of life. Next, we performed 
a series of reversed hierarchical regression analyses. 
Before examining regression assumptions and per-
forming the regression analyses, we centred the data 
to control for multicollinearity using the deviation 
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score approach (subtracting the mean).26 The 
Kolmogorov–Smirnov test affirmed that the distribu-
tion of both stigma scales was not normal (P < 0.05). 
Because we also found heteroscedasticity (increasing 
variance with higher predicted scores), we chose to 
perform the stigma models using gamma regression 
analyses. According to Kolmogorov–Smirnov tests, 
the errors in the quality-of-life models were not nor-
mally distributed either, but they did not display a 
definite pattern. We therefore performed the quality-
of-life models with a normal regression using Huber–
White robust estimators. When using Huber–White 
robust standard errors, there is no longer a single 
population variance; standard R2 measures become 
meaningless and, if used, should be interpreted with 
great care. To assess model fit, we therefore report 
likelihood ratio tests, instead. These tests compare the 
fitted model with the ‘intercept-only’ model.
One regression model was performed for the 
extent of limitations. Two regression models were 
performed for stigma: one predicting enacted 
stigma and one predicting self-stigma. Four regres-
sion models were performed for quality of life, one 
for each subscale. We then excluded variables from 
further analysis based on their P-value, starting 
with the highest P-value, following a backwards 
elimination procedure.27 We stopped the deletion 
of variables once only significant effects remained 
(cut-off alpha 0.05, one-tailed). We also used log-
likelihood ratio tests in this deletion procedure to 
assess whether our model deteriorated significantly 
with the deletion of each variable.
This procedure enabled us to greatly reduce 
the risk of finding spurious results, because we 
began with our directed expectations (as formu-
lated in the introduction) and weeded out the 
non-significant effects. We used one-tailed tests 
for our directed expectations; the tables in the 
results section, however, flag the conventional 
two-tailed P-values. Since in the symmetric t-dis-
tribution a two-tailed P-value of 0.1 is equivalent 
to a one-tailed P-value of 0.05, we flagged 0.1 as 
the first significance level.
Results
A total of 185 patients (61% response rate) partici-
pated in the study. Non-respondents did not differ 
from respondents in gender (χ2 = 1.506, not signifi-
cant (ns)), age (t = −1.964, ns) and years since 
diagnosis (t = −0.466, ns).
Table 1 presents the background, disease-related 
and study variables of respondents. Patients were 
most female (68%), with an average age of 60 
years, mean number of years since diagnosis was 
23.6 years and most participants were able to walk 
(with or without assistance). Most patients had a 
relapsing remitting or secondary progressive dis-
ease course and experienced moderate to serious 
limitations. All patients experienced stigma, but 
severity levels were low. Patients experienced 
good levels of sense of coherence and moderate to 
good levels in all quality-of-life domains.
Table 2 shows that patients who experienced a 
higher level of limitations suffered more from 
stigma: enacted stigma (B = 0.044, P < 0.05) and 
self-stigma (B = 0.063, P < 0.01). However, 
patients with a higher sense of coherence experi-
enced a lower level of limitations (B = −0.063, P < 
0.01) and suffered less from stigma: enacted stigma 
(B = −0.030, P < 0.01) and self-stigma (B = −0.037, 
P < 0.01).
Table 3 shows that patients with a higher sense 
of coherence experienced better quality of life: 
physical health (B = 0.059, P < 0.01), psychologi-
cal health (B = 0.062, P < 0.01), social relation-
ships (B = 0.052, P < 0.01) and environmental 
aspects (B = 0.030, P < 0.01). Patients who experi-
enced a higher level of limitations experienced 
poorer quality of life. However, this effect was pre-
sent in only two quality-of-life domains: physical 
health (B = −0.364, P < 0.01) and psychological 
health (B = −0.089, P < 0.05). Patients who suf-
fered more from stigma also experienced poorer 
quality of life. Self-stigma was negatively related 
to all quality-of-life domains: physical health (B = 
−0.073, P < 0.01), psychological health (B = 
−0.089, P < 0.01), social relationships (B = −0.124, 
P < 0.01) and environmental aspects (B = −0.052, 
P < 0.01). Enacted stigma was negatively related 
only to physical health (B = −0.085, P < 0.10).
Discussion
We examined the impact of perceived limitations, 
stigma and sense of coherence on quality of life in 
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Table 1. Patient characteristics and study variables (n = 185).
Variable Cohort
Gender, n (%)
 Male 59 (32)
 Female 125 (68)
Age (years)
 Mean (SD) 60.0 (10.8)
 Range 33–88
Marital status, n (%)
 Married/partnership 139 (76)
 Unmarried/widowed/divorced 44 (24)
Educational level, n (%)
 Primary or secondary school/vocational training 139 (76)
 Higher professional education/university 43 (24)
Employment status (more answers possible), n (%)
 Employment 18 (10)
 Voluntary work 14 (8)
 (Partially) retired due to multiple sclerosis 97 (52)
 Housewife/househusband 47 (25)
 Retired due to age 48 (26)
Disease progression multiple sclerosis, n (%)
 Primary progressive 9 (5)
 Secondary progressive 84 (46)
 Relapsing remitting 89 (49)
Years since diagnosis
 Mean (SD) 23.6 (8.4)
 Range 6–66
Walking ability (EDSS), n (%)
 0–4.5 (walk without assistance) 67 (37)
 ≥4.5–<7 (walk with assistance) 66 (36)
 ≥7–<10 (wheelchair or bed) 49 (27)
Extent of limitationsa
 Mean (SD) 5.6 (2.9)
Stigma (SSCI)a
 Enacted stigma
  Prevalence (>0) 170 (100)
  Mean (SD) 7.2 (5.9)
 Self-stigma
  Prevalence (>0) 154 (91)
  Mean (SD) 11.4 (9.2)
Sense of coherence (SOC-13)a
 Mean (SD) 67.5 (13.3)
Quality of life (WHOQOL-BREF),a mean (SD)
 Physical health 13.5 (3.0)
 Psychological health 13.4 (2.0)
 Social relationships 14.6 (2.8)
 Environmental aspects 13.7 (1.4)
EDSS: Expanded Disability Status Scale (score range, 0–10); SSCI: Stigma Scale for Chronic Illness: enacted stigma (score range, 0–44), self-stigma 
(score range, 0–52); SOC: Sense of Coherence Scale (score range, 13–91); WHOQOL-BREF: World Health Organization Quality of Life measure-
ment instrument – abbreviation version (score range, 0–20).
aHigher scores indicate a higher extent of limitations, more stigma, a higher sense of coherence and better quality of life.
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multiple sclerosis patients. Our results showed that 
most patients experienced moderate to severe limi-
tations, while all patients experienced stigma with 
low to moderate severity levels. Patients experi-
enced a relatively high sense of coherence and 
moderate to good levels of quality of life in all 
domains. In addition, we found that patients with 
more limitations and stigma experienced poorer 
quality of life, while patients with a higher level of 
sense of coherence experienced better quality of 
life. We also found that patients with a higher sense 
of coherence experienced a lower level of limita-
tions and less stigma.
To our knowledge, no previous studies have 
examined the effect of sense of coherence, per-
ceived limitations and stigma on quality of life in 
multiple sclerosis patients. However, our find-
ings are in line with studies which have found a 
positive relationship between sense of coherence 
and quality of life in other patient groups11 and 
studies which have found a negative relationship 
between stigma and quality of life in multiple 
sclerosis.28
This is the first study that examined the 
impact of sense of coherence on limitations, the 
impact of sense of coherence and limitations on 
stigma and the impact of sense of coherence, 
limitations and stigma on quality of life in multi-
ple sclerosis in a relatively large sample of mul-
tiple sclerosis patients. A potential limitation 
might be that this study was part of a cohort 
study. Since this cohort did not include new 
patients (≤10 years since diagnosis), the average 
age of the multiple sclerosis patients was higher 
than in multiple sclerosis patients in a Dutch epi-
demiological study.29 The ratio of female to male 
patients was slightly above 2:1, which is equal to 
the ratio found in other Dutch and international 
studies.28–31 We therefore recommend some cau-
tion in generalizing our results to other popula-
tions of multiple sclerosis patients. We also 
recommend caution in generalizing these results 
to other patient groups, even though we would 
expect to find similar results in patients with 
comparable chronic diseases. Since we found no 
significant difference between respondents and 
non-respondents in terms of gender, age and 
years since diagnosis, it is safe to presume that 
non-response did not alter our findings. Finally, 
even though patients with a higher sense of 
coherence experienced a lower level of limita-
tions, less stigma and better quality of life, we 
must emphasize that we performed an explora-
tive study and therefore cannot determine causal 
effects. We do, however, believe that we can rea-
sonably speculate on the clinical implications of 
our findings and recommend further research.
The measurement instruments used in this 
study could be applied by clinicians for screening 
purposes. When considering stigma reduction 
strategies and improving patients’ sense of coher-
ence and quality of life, clinicians should be alert 
to selecting patient-centred interventions which 
employ direct social contact. For example, group-
based cognitive behavioural therapy has proved a 
promising intervention for reducing stigma and 
increasing multiple sclerosis patients’ sense of 
coherence, self-efficacy and quality of life.32–34 
Policymakers and social scientists play an impor-
tant role in improving public awareness of issues 
such as stigma and could make a larger contribu-
tion to alleviating these issues by examining and 
developing interventions which focus on improv-
ing participation, social inclusion and quality of 
life for vulnerable groups in society.34
Our study was the first to combine and examine 
the impact of sense of coherence, perceived limita-
tions, stigma and quality of life in multiple sclero-
sis. Therefore, we recommend confirmative studies 
to assess these associations, preferably longitudi-
nally and in a cohort of patients comparable in age 
to the population. Further research should focus on 
examining whether sense of coherence is a buffer 
for the negative impact of perceived limitations 
and stigma on quality of life. Further research 
should also focus on developing interventions 
which reduce stigma and improve sense of coher-
ence and quality of life in multiple sclerosis 
patients.32–34
This study showed that stigma is prevalent 
among multiple sclerosis patients with limitations, 
while the extent to which limitations and stigma 
impact quality of life might depend on patients’ 
sense of coherence. To improve a patient’s quality 
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of life, clinicians can consider patient-centred 
interventions to improve sense of coherence and to 
reduce limitations and stigma.
Clinical Messages
•• Stigma was highly prevalent among mul-
tiple sclerosis patients.
•• Patients with a higher level of limitations 
experienced more stigma.
•• Perceived limitations and stigma were 
detrimental to quality of life.
•• Patients with a higher sense of coherence 
experienced less limitations, less stigma 
and better quality of life.
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